Trubion has a growing pipeline of drug candidates in clinical and pre-clinical development, as shown below. The company's initial focus is on building a portfolio of novel, proprietary, small modular immunopharmaceutical (SMIP™) product candidates.
 |
 |
|
 |
 |
 |
Trubion has a growing pipeline of drug candidates in clinical and pre-clinical development, as shown below. The company's initial focus is on building a portfolio of novel, proprietary, small modular immunopharmaceutical (SMIP™) product candidates.